For these individuals, the OPG/TRAIL ratio-associated risk was higher (HR 3.44 [95% CI 2.55–4.66]) than that for individuals without hypertension (HR 1.64 [95% CI 1.16–2.33]). This evidence concerns the gene TNFRSF11B and hypertensive disorder.